0 items USD 0.00Search
Your search for "globaldata waldenstrom macroglobulinemia global clinical trials review h1 2016" gave back 48391 results.
The “Waldenstrom Macroglobulinemia Therapeutics Industry Forecast” looks at past sales and reviews total world Waldenstrom Macroglobulinemia...
Catalog:
LPI
March 2023
Price: USD 3,660.00
The global Waldenstrom Macroglobulinemia Therapeutics market size was valued at US$ million in 2023. With growing demand in downstream market, the...
Catalog:
LPI
February 2024
Price: USD 3,660.00
The “Waldenstrom's Macroglobulinemia Treatment Industry Forecast” looks at past sales and reviews total world Waldenstrom's...
Catalog:
LPI
February 2023
Price: USD 3,660.00
Highlights The global Waldenstrom's Macroglobulinemia Treatment market was valued at US$ million in 2022 and is anticipated to reach US$ million...
Catalog:
MRRPB5
February 2023
Price: USD 2,900.00
Market Analysis and Insights: Global Waldenstrom's Macroglobulinemia Treatment Market The global Waldenstrom's Macroglobulinemia Treatment...
Catalog:
MRRPB5
July 2023
Price: USD 4,900.00
As the global economy recovers in 2021 and the supply of the industrial chain improves, the Waldenstrom's Macroglobulinemia Treatment market...
Catalog:
Arsta
January 2022
Price: USD 3,360.00
The global BTK Inhibitor market size is projected to grow from US$ 866.7 million in 2022 to US$ 1834.6 million in 2029; it is expected to grow at a...
Catalog:
LPI
June 2023
Price: USD 3,660.00
The global Bruton Tyrosine Kinase (BTK) Inhibitor market size is projected to grow from US$ 866.7 million in 2022 to US$ 1834.6 million in 2029; it...
Catalog:
LPI
June 2023
Price: USD 3,660.00
The global BTK Inhibitor market size is expected to reach $ 1825.9 million by 2029, rising at a market growth of 10.4% CAGR during the forecast...
Catalog:
GIR
July 2023
Price: USD 4,480.00
The global BTK Inhibitor market size was valued at USD 911.6 million in 2022 and is forecast to a readjusted size of USD 1825.9 million by 2029 with...
Catalog:
GIR
July 2023
Price: USD 3,480.00
The global Bruton Tyrosine Kinase (BTK) Inhibitor market size was valued at USD 911.6 million in 2022 and is forecast to a readjusted size of USD...
Catalog:
GIR
July 2023
Price: USD 3,480.00
The global Bruton Tyrosine Kinase (BTK) Inhibitor market size is expected to reach $ 1825.9 million by 2029, rising at a market growth of 10.4% CAGR...
Catalog:
GIR
July 2023
Price: USD 4,480.00
Bruton’s tyrosine kinase (BTK) is a key component of the B-cell receptor (BCR) signalling pathway. BTK is an important protein that is a regulator of...
Catalog:
LPI
March 2023
Price: USD 3,660.00
Summary Anorexia Nervosa Clinical Trials market research report provides the newest industry data and industry future trends, allowing you to...
Catalog:
ICRW
February 2021
Price: USD 2,960.00
Innovation and Clinical Trial Tracking Factbook 2017: An Assessment of the Pharmaceutical Pipeline Summary GBI Research’s latest report, “Innovation...
CBR Pharma Insights
May 2017
Price: USD 2,995.00
